Skip to main content

Table 4 The Relationship between Therapeutic Agents and Platelet Recovery Following Nadir in Yeast

From: Dose escalation study of an anti-thrombocytopenic agent in patients with chemotherapy induced thrombocytopenia

RNA Fragments

Dose

Chemotherapy

Patient Number

Median Platelet Counts

Range

Kruskall Wallis

Yeast

60

Non mito, non Platinum

5

 

21-235

 
  

Carboplatin

4

 

56-130

 
  

Cisplatin

2

 

101-206

 
  

Mitomycin C

1

 

101

 

Yeast

80

Non mito, non Platinum

6

 

57-244

 
  

Carboplatin

7

 

33-121

 
  

Cisplatin

1

 

185

 
  

Mitomycin C

3

 

40-90